Tatsis Ourania 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Mar 6, 2025
Insider Transaction Report
Form 4
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
Transactions
- Sale
Common Stock
2025-03-04$485.49/sh−4,058$1,970,118→ 54,481 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 11/22/2024.